111 HUNTINGTON AVENUE,
BOSTON , MA, 02199
BOSTON , MA, 02199
Summary
The fund seeks capital appreciation by investing in companies across any size outside the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team focuses on foreign securities, including emerging market securities.
The team favors compani More
Link
Directors
Nov 12, 2021- Laurie J. Thomsen
- Peter D. Jones
- John P. Kavanaugh
- Michael W. Roberge
- Maryanne L. Roepke
- Clarence Otis, Jr.
- Maureen R. Goldfarb
- James W. Kilman, Jr.
- Steven E. Buller
- Robert J. Manning
- John A. Caroselli
Chief Compliance Officer
- Martin J. Wolin
Fund Manager(s)
- Victoria Higley
- Camille Lee
Price
- 52-Week High/Low
- $23.23 - $18.78
- Turnover
- 20%
- Expense Ratio
- 1.81%
Company Name |
Holding |
| Roche Holding AG | 3.44 % |
| Nestle SA | 3.29 % |
| Novo Nordisk A/S | 3.28 % |
| Schneider Electric SE | 2.53 % |
| Linde PLC | 2.37 % |
| LVMH Moet Hennessy Louis Vuitton SE | 2.32 % |
| Aon PLC | 1.72 % |
| Hitachi Ltd | 1.63 % |
| MFS Institutional Money Market Portfolio | 1.6 % |
| UBS Group AG | 1.59 % |
| More | 1.59 % |
Documents
Performance
YTD
-
3 Year
23.34%
5 Year
19.47%
Best
31.45%
2003
Worst
-42.96%
2008
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | - | - | -9.5% | 1.7% | -19.9% | 11.7% | -1% | 7.1% | -3.9% |
| Q2 | - | - | - | - | 5.4% | 16.2% | 3.4% | 0.1% | 8% | 0.1% |
| Q3 | - | - | - | - | -0.4% | 7.2% | -1% | 2.1% | 4.4% | 5.4% |
| Q4 | - | - | - | - | 3.5% | 12.2% | 8.2% | -14% | 5.3% | -3.3% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0% | 0% | -10% | 11% | 12% | 25% | -15% | 27% | -2% |
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EBRIX | - | - | - | -10% | 11% | 12% | 25% | -15% | 27% | -2% |
| S&P 500 | - | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% |
| Alpha | - | - | - | 12% | -16% | -4% | -3% | -9% | 8% | -11% |